Literature DB >> 7992697

Radiofrequency catheter ablation of cardiac arrhythmias in pediatric patients.

G F Van Hare1.   

Abstract

Since their introduction 4 years ago in children, radiofrequency ablation techniques for definitive management of cardiac arrhythmias have evolved dramatically. All forms of abnormal tachycardia in children are now amenable to ablation. The success rates are high, and the procedure-related and short-term risks of ablation are very low. Radiofrequency ablation offers significant advantages over cardiac surgery as well as over long-term or lifetime administration of antiarrhythmic medications. The application of these techniques to children requires, in addition to experience in electrophysiology, a thorough knowledge of developmental issues in children, pediatric catheterization techniques, and a detailed knowledge of congenital heart disease. Although the impressive safety of the technique in the short term suggests that it should be considered as first-choice therapy for children with serious tachyarrhythmias, unresolved questions about the long-term safety of the technique suggest that a cautious approach should be taken in the application of radiofrequency ablation to the pediatric age group, and particularly in younger children and infants.

Entities:  

Mesh:

Year:  1994        PMID: 7992697

Source DB:  PubMed          Journal:  Adv Pediatr        ISSN: 0065-3101


  3 in total

1.  Histiocytoid cardiomyopathy and ventricular non-compaction in a case of sudden death in a female infant.

Authors:  Erik Edston; Nasrin Perskvist
Journal:  Int J Legal Med       Date:  2008-04-30       Impact factor: 2.686

2.  Internal jugular/subclavian venous access in electrophysiology study and ablation.

Authors:  Shomu Bohora; Jaganmohan Tharakan
Journal:  Indian Pacing Electrophysiol J       Date:  2009-07-01

3.  Safety and Efficacy of Radiofrequency Catheter Ablation for Tachyarrhythmia in Children Weighing Less Than 10 kg.

Authors:  Noriyasu Ozaki; Yoshihide Nakamura; Tsugutoshi Suzuki; Jun Yoshimoto; Keiko Toyohara; Hitoo Fukuhara; Hiroshi Katayama; Kanta Kishi; Yutaka Odanaka; Hiroshi Tamai
Journal:  Pediatr Cardiol       Date:  2017-11-08       Impact factor: 1.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.